当前位置:首页 - 行情中心 - 易瑞生物(300942) - 财务分析

易瑞生物

(300942)

  

流通市值:25.72亿  总市值:31.51亿
流通股本:3.27亿   总股本:4.01亿

易瑞生物(300942)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-0.07亿元,每股收益-0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益84343.75万元,未分配利润13133.31万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产139613.49万元,负债55269.74万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入36,475,073.45254,106,487.66165,099,285.79112,111,327.49
营业总成本44,390,455.72332,443,054.25244,638,062.81184,963,695.48
营业利润-7,342,377.09-175,301,186.82-95,086,336.81-83,792,972.32
利润总额-7,329,724.06-177,798,044.1-96,238,802.25-83,995,058.61
净利润-7,273,762.66-184,983,355.31-99,216,611.87-69,675,890.25
其他综合收益-66,277.39400,468.311,803,253.062,622,166.44
综合收益总额-7,340,040.05-184,582,887-97,413,358.81-67,053,723.81
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计749,654,790.93737,670,284.61822,383,647.31542,567,633.12
非流动资产合计646,480,086.09618,668,994.32652,935,011.81640,758,053.99
资产总计1,396,134,877.021,356,339,278.931,475,318,659.121,183,325,687.11
流动负债合计130,901,404.81136,927,085.34132,735,232.4145,305,756.38
非流动负债合计421,795,946.85370,683,961.98394,224,665.37140,857,299.53
负债合计552,697,351.66507,611,047.32526,959,897.77286,163,055.91
归属于母公司股东权益合计841,857,760.16848,993,883.06948,574,979.54897,364,388.97
股东权益合计843,437,525.36848,728,231.61948,358,761.35897,162,631.2
负债和股东权益合计1,396,134,877.021,356,339,278.931,475,318,659.121,183,325,687.11
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计65,457,841.42259,925,250.75202,566,641.66116,724,611.33
经营活动现金流出小计56,045,035.64297,175,103.64260,955,442.65188,492,983.83
经营活动产生的现金流量净额9,412,805.78-37,249,852.89-58,388,800.99-71,768,372.5
投资活动现金流入小计30,357,118.7408,708,797.78419,425,131.3311,380,328.77
投资活动现金流出小计66,009,330.37474,936,130.28329,997,753.53290,127,239.37
投资活动产生的现金流量净额-35,652,211.67-66,227,332.589,427,377.7721,253,089.4
筹资活动现金流入小计52,000,000392,236,027.19391,965,707.3248,331,552.25
筹资活动现金流出小计5,879,977.359,110,980.9626,428,470.4923,162,112.45
筹资活动产生的现金流量净额46,120,022.7333,125,046.23365,537,236.8325,169,439.8
汇率变动对现金及现金等价物的影响-1,278,804.524,920,327.334,794,538.887,260,250.03
现金及现金等价物净增加额18,601,812.29234,568,188.17401,370,352.49-18,085,593.27
期末现金及现金等价物余额500,350,687.09481,748,874.8648,551,039.12229,095,093.36
TOP↑